---
figid: PMC5895645__fimmu-09-00579-g001
figlink: /pmc/articles/PMC5895645/figure/F1/
number: F1
caption: Metabolic and vascular effects of insulin. Under physiologic conditions,
  the activated insulin receptor on endothelial cells leads to phosphorylation of
  endothelial nitric oxide synthase (eNOS) via activation of insulin receptor substrate
  (IRS) and phosphoinositide-3-kinase (a). This results in vasodilation via NO production.
  This branch also regulates GLUT4 translocation and glucose uptake in muscle cells.
  The mitogen-activated protein kinase (MAPK) pathway controls secretion of vasoconstrictive
  ET-1 in endothelial cells, and cell growth and mitogenesis in cells at large. Inflammation
  reduces NO production via blocking insulin receptor signaling at the level of the
  IRS-1 (b).
pmcid: PMC5895645
papertitle: 'Systemic Inflammation and Cardiovascular Comorbidity in Psoriasis Patients:
  Causes and Consequences.'
reftext: Wolf-Henning Boehncke. Front Immunol. 2018;9:579.
pmc_ranked_result_index: '29517'
pathway_score: 0.6947756
filename: fimmu-09-00579-g001.jpg
figtitle: Metabolic and vascular effects of insulin
year: '2018'
organisms:
- Homo sapiens
ndex: 9566b346-df1e-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5895645__fimmu-09-00579-g001.html
  '@type': Dataset
  description: Metabolic and vascular effects of insulin. Under physiologic conditions,
    the activated insulin receptor on endothelial cells leads to phosphorylation of
    endothelial nitric oxide synthase (eNOS) via activation of insulin receptor substrate
    (IRS) and phosphoinositide-3-kinase (a). This results in vasodilation via NO production.
    This branch also regulates GLUT4 translocation and glucose uptake in muscle cells.
    The mitogen-activated protein kinase (MAPK) pathway controls secretion of vasoconstrictive
    ET-1 in endothelial cells, and cell growth and mitogenesis in cells at large.
    Inflammation reduces NO production via blocking insulin receptor signaling at
    the level of the IRS-1 (b).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAPK11
  - NOS3
  - EDN1
  - SLC2A4
  - IRS1
  - MAPK9
  - MAPK8
  - AKT3
  - AKT1
  - AKT2
  - IRS4
  - MAPK10
  - MAPK13
  - MAPK12
  - KRAS
  - IRS2
  - MAPK14
  - NRAS
  - MAP2K2
  - MAP2K1
  - MAPK3
  - MAPK1
  - HRAS
  - Glucose
  - Cancer
genes:
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: ENOS
  symbol: eNOS
  source: hgnc_alias_symbol
  hgnc_symbol: NOS3
  entrez: '4846'
- word: ET-1
  symbol: ET1
  source: hgnc_alias_symbol
  hgnc_symbol: EDN1
  entrez: '1906'
- word: GLUT4
  symbol: GLUT4
  source: hgnc_prev_symbol
  hgnc_symbol: SLC2A4
  entrez: '6517'
- word: IRS
  symbol: IRS
  source: bioentities_symbol
  hgnc_symbol: IRS1
  entrez: '3667'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: IRS
  symbol: IRS
  source: bioentities_symbol
  hgnc_symbol: IRS4
  entrez: '8471'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: IRS
  symbol: IRS
  source: bioentities_symbol
  hgnc_symbol: IRS2
  entrez: '8660'
- word: IRS1
  symbol: IRS1
  source: hgnc_symbol
  hgnc_symbol: IRS1
  entrez: '3667'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: PKB/
  symbol: PKB
  source: hgnc_alias_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: Mek
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: Mek
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
chemicals:
- word: Glucose
  source: MESH
  identifier: D005947
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC5895645__F1
redirect_from: /figures/PMC5895645__F1
figtype: Figure
---
